April 18, 2013
The United States Supreme Court is hearing an interesting case this week regarding Myriad Genetics’ right to patent the cancer-causing genes, BRCA 1 and BRCA2. The court’s decision, when made, will have important implications for future physicians and researchers with regards to their ability to do research and work in the ever-evolving field of genetics. Basically, if you’re planning to practice medicine, as most of you reading this blog are, the outcome of this case is very important for your future practice!
The essential question at stake is whether or not you can patent a gene or a particular variant …...read more